Azacitidine
Who holds supplier records for Azacitidine? 19 organisations hold a current record for Azacitidine: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (9), China (4), Australia (1), France (1) and 3 other countries (3); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Azacitidine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/azacitidine
Reading the evidence
- 19 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 11 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Azacitidine expires 3 Jun 2030. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (19)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Azacitidine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 38672 · latest filing Aug 2023
- ARTHUR GROUP LLCAustraliaActive DMF 39819 · latest filing Apr 2024
- CHEMWERTH INCFranceActive DMF 23416 · latest filing Dec 2009
- Chongqing Sintaho Pharmaceutical Co., Ltd.ChinaActive DMF 28107 · latest filing Mar 2014
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 23564 · latest filing Feb 2010
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 32272 · latest filing Dec 2017
- HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTDChinaActive DMF 44286 · latest filing Jun 2026
- Intas Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 27821 · latest filing Dec 2013
- Jiangsu Hansoh Pharmaceutical Group Company LimitedChina Company GMP cert on recordActive DMF 32864 · latest filing Sept 2018
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 26846 · latest filing Feb 2013
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 28100 · latest filing Apr 2014
- OLON SPAItaly Company GMP cert on recordActive DMF 42276 · latest filing Jul 2025
- Reliance Life Sciences Pvt. Ltd.India Company GMP cert on recordActive DMF 36422 · latest filing May 2022
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 22360 · latest filing Dec 2008
- Shandong Anhong Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 29771 · latest filing Sept 2015
- SHILPA PHARMA LIFESCIENCES LTDIndiaActive DMF 27487 · latest filing Sept 2013
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 29864 · latest filing Sept 2016
- SUZHOU YIFAN PHARMACEUTICAL CO LTDActive DMF 43196 · latest filing Dec 2025
- TAPI NL BVNetherlandsActive DMF 26126 · latest filing Jun 2012
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Azacitidine are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Italy · Inactive DMF 25265 · filed Sept 2011
- MYLAN LABORATORIES LTDInactive DMF 22801 · filed May 2009
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (16 listed products contain Azacitidine). The latest listed patent expires 3 Jun 2030. The latest listed exclusivity runs to 20 May 2029. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Azacitidine is a chemical compound used primarily in the treatment of myelodysplastic syndromes. It is a pyrimidine nucleoside analogue of cytidine with antineoplastic activity.
Chemical identity
- IUPAC name
- 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one
- Canonical SMILES
- C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N
- InChIKey
- NMUSYJAQQFHJEW-KVTDHHQDSA-N
- Synonyms
- Vidaza API, 5-azacitidine, nsc-102816, onureg, u-18,496, u-18496, vidaza
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nucleoside Metabolic Inhibitor
- Mechanism of action
- Nucleic Acid Synthesis Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Azacitidine?
19 organisations hold an active US FDA Type II Drug Master File or a CEP for Azacitidine: APITORIA PHARMA PRIVATE LTD (India), ARTHUR GROUP LLC (Australia), CHEMWERTH INC (France), Chongqing Sintaho Pharmaceutical Co., Ltd. (China), Dr. Reddy's Laboratories Ltd. (India), Hetero Labs Limited (India), HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (China) and Intas Pharmaceuticals Ltd. (India), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Azacitidine Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 38672), ARTHUR GROUP LLC (DMF 39819), CHEMWERTH INC (DMF 23416), Chongqing Sintaho Pharmaceutical Co., Ltd. (DMF 28107), Dr. Reddy's Laboratories Ltd. (DMF 23564), Hetero Labs Limited (DMF 32272), HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (DMF 44286) and Intas Pharmaceuticals Ltd. (DMF 27821) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Azacitidine records mean?
2 organisations have only inactive Type II DMFs for Azacitidine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Azacitidine?
Yes. The latest patent listed for an approved US product containing Azacitidine expires 3 Jun 2030, across 16 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Azacitidine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Azacitidine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.